More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$60494194
EPS
0.21
P/E ratio
15
Price to sales
0.41
Dividend yield
4.193%
Beta
0.712866
Previous close
$4.97
Today's open
$4.94
Day's range
$4.67 - $5.20
52 week range
$3.90 - $11.71
show more
CEO
Steven R. Fife
Employees
223
Headquarters
Lehi, UT
Exchange
NASDAQ Capital Market
Shares outstanding
12682221
Issue type
Common Stock
Consumer Staples
Consumer Products - Healthcare
LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript
LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript
Seeking Alpha • Nov 10, 2026

What Lifevantage (LFVN) Said on Its Q1 Earnings Call
Lifevantage NASDAQ: LFVN reported a 22% decline in revenue for its fiscal first quarter and outlined a strategy to overhaul its brand, digital sales tools and cost structure as it works to stabilize the business.
MarketBeat • Nov 9, 2026

LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its quarter ended September 30, 2026. First Quarter Fiscal 2027 Summary*: Revenue was $37.1 million, a decrease of 22.0% from the prior year period; Revenue in the Americas decreased 22.2%, and revenue in Asia/Pacific & Europe decreased 21.2%; Net loss per diluted share was $0.02, versus net income per diluted share of $0.17 a year ago; Adjusted earnings per diluted share was $0.05, compared to $0.18 a year ago; and Adjusted EBITDA was $1.9 million compared to $3.9 million a year ago.
GlobeNewsWire • Nov 9, 2026

LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid December 15, 2026 to all stockholders of record at the close of business on December 1, 2026.
GlobeNewsWire • Nov 9, 2026

Lifevantage (LFVN) Surpasses Q1 Earnings Estimates
Lifevantage (LFVN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.18 per share a year ago.
Zacks Investment Research • Nov 10, 2026

New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*
SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone disruptors, and pesticides—affect cells and the role Protandim® Nrf2 can play in helping protect against their impact. † These findings further reinforce LifeVantage's position as a pioneer in nutrigenomics and the science behind its products that ignite the human body's natural defense systems.
GlobeNewsWire • Oct 29, 2026

LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2026, after the stock market closes on Monday, November 9, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
GlobeNewsWire • Oct 26, 2026

New Strong Sell Stocks for October 19th
CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026.
Zacks Investment Research • Oct 19, 2026

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company's President and Chief Executive Officer, under the Company's 2026 New Employee Long-Term Incentive Plan. The awards were granted pursuant to the key executive benefits agreement between the Company and Mr. Moorehead, dated as of April 15, 2026, as an inducement material to Mr. Moorehead's employment in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewsWire • Oct 12, 2026

LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
Lifevantage NASDAQ: LFVN executives outlined a turnaround plan centered on strengthening the company's brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion.
MarketBeat • Sep 24, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Lifevantage Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.